Anti-tumor Activity of N4 [(E)-1-(2-hydroxyphenyl) Methylidene], N4-[(E)-2-Phenylethylidene], N4 [(E,2E)-3-Phenyl-2-propenylidene], and N4 [(E)ethylidene] Isonicotinohydrazide on K562 and Jurkat Cell Lines
2010

Anti-tumor Activity of New Isonicotinohydrazide Compounds

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Shabani F, Ghammamy S, Jahazi A, Siavoshifar F

Primary Institution: Islamic Azad University, Ardabil, Iran

Hypothesis

The new isonicotinohydrazide compounds exhibit anti-tumor activity against K562 and Jurkat cell lines.

Conclusion

The new compounds show enhanced inhibitory activity against cancer cells, indicating potential for chemotherapy.

Supporting Evidence

  • The compounds were synthesized using a water eliminated mechanism.
  • IC50 values were determined for each compound against K562 and Jurkat cell lines.
  • The compounds showed varying degrees of cytotoxicity, with some exhibiting significant inhibitory effects.

Takeaway

Scientists created new compounds that can help fight cancer, and they found that these compounds can stop cancer cells from growing.

Methodology

The compounds were synthesized and tested for cytotoxicity against K562 and Jurkat cell lines using IC50 measurements.

Limitations

The study does not explore the long-term effects of the compounds or their mechanisms of action in detail.

Digital Object Identifier (DOI)

10.4103/0975-1483.71638

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication